09:18 AM EDT, 06/26/2024 (MT Newswires) -- Health care stocks were mixed pre-bell Wednesday, with the iShares Biotechnology ETF ( IBB ) down 0.1% and the Health Care Select Sector SPDR Fund ( XLV ) up 0.5% recently.

Savara (SVRA) rose past 17% after saying the phase 3 IMPALA-2 clinical trial assessing the efficacy and safety of Molgramostim in adult patients with autoimmune pulmonary alveolar proteinosis met its primary endpoint.

Kiniksa Pharmaceuticals ( KNSA ) said Samsung Biologics has agreed to perform technology transfer, process performance qualification, manufacturing and supply services for the supply of the company's Arcalyst drug substance. Kiniksa Pharmaceuticals ( KNSA ) was up nearly 1% premarket.

Taysha Gene Therapies ( TSHA ) declined by over 12% after it started an up to $75 million offering of its shares and pre-funded warrants.